Skip to main content
. 2018 Jul 26;11(5):1155–1159. doi: 10.1016/j.tranon.2018.07.009

Table 3.

Incidence of Treatment-Related Toxicities for Each Dose Cohort

Adverse Events No. of Patients (All Grades)
Cohort 1 Cohort 2 Cohort 3 Cohort 4 Total (%)
Hypertension 1 1 1 1 4 (33.3)
HFS 1 2 0 1 4 (33.3)
Proteinuria 0 2 0 1 3 (25.0)
Nausea 1 1 0 1 3 (25.0)
Neutropenia 0 1 1 1 3 (25.0)
Fatigue 1 1 2 1 5 (41.6)
Hyperbilirubinemia 1 0 0 0 1 (8.3)
Diarrhea 0 1 0 0 1 (8.3)
Thrombocytopenia 0 0 0 1 1 (8.3)

HFS, hand-foot syndrome.